TABLE 3.
Genes in eSFs differentially induced by rSP and MV fraction from infected individualsa
rSP from HIV-infected participants vs rSP from uninfected individuals |
MVs from HIV-infected participants vs MVs from uninfected individuals |
||||
---|---|---|---|---|---|
Gene regulation and gene | P value | Fold change in expression | Gene regulation and gene | P value | Fold change in expression |
Upregulated by rSP from HIV-infected individuals | Upregulated by MV HIV-infected individuals | ||||
CXCL1 | 0.03 | 4.89 | CXCL1 | 0.04 | 3.37 |
HIST1H4C | 0.02 | 1.87 | |||
CCR10 | 0.04 | 1.54 | |||
Downregulated by rSP from HIV-infected individuals | Downregulated by MVs from HIV-infected individuals | ||||
RPS10P7 | 0.03 | 4.17 | |||
LOC101928120 | 0.02 | 1.80 | |||
DBNDD2 | 0.02 | 1.80 | |||
LPCAT1 | 0.03 | 1.69 | |||
UFSP1 | <0.001 | 1.64 | |||
PSMB8-AS1 | 0.02 | 1.60 | |||
IN080B | 0.01 | 1.57 |
Genes with a ≥1.5-fold change in expression between treatment groups with a P value of <0.05.